vTv Therapeutics Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €36.93M +273.3% -€34.37M -24.4% -93.1% +3.7 pp N/A N/A
    (estimated) €9.89M +∞% -€45.46M +21.5% -459.5% -4.6 pp N/A N/A
    (estimated) €0.00 +NaN% -€37.41M +24.7% N/A N/A N/A
    (estimated) €0.00 +NaN% -€30.01M +44.6% N/A N/A N/A
    (estimated) €0.00 -100.0% -€20.75M +31.8% N/A N/A N/A
    €867.45K +∞% -€15.75M -8.8% -1,815.3% -18 pp -€21.59M +32.6% -2,488.4% -25 pp
    €0.00 -100.0% -€17.27M -19.2% N/A -€16.28M +19.2% N/A
    €1.72M -49.6% -€21.39M +41.4% -1,242.5% -8.0 pp -€13.65M -17.1% -792.9% -3.1 pp
    €3.42M -37.6% -€15.12M +100.9% -442.7% -3.1 pp -€16.47M +7.3% -482.1% -2.0 pp
    €5.47M +132.1% -€7.53M -59.8% -137.6% +6.6 pp -€15.35M -21.6% -280.6% +5.5 pp
    €2.36M -77.8% -€18.71M +177.3% -793.7% -7.3 pp -€19.57M -14.5% -830.2% -6.1 pp
    €10.61M +4,172.9% -€6.75M -51.0% -63.6% +55 pp -€22.90M -39.7% -215.9% +150 pp
    €248.21K -54.1% -€13.77M -1.3% -5,547.8% -30 pp -€37.96M -7.5% -15,293.1% -77 pp
    €540.77K +22.2% -€13.95M -40.5% -2,579.2% +27 pp -€41.05M +30.6% -7,590.2% -4.9 pp
    €442.68K -66.5% -€23.45M -23.8% -5,298.3% -30 pp -€31.42M +19.8% -7,098.7% -51 pp
    €1.32M +58.7% -€30.79M -25.1% -2,330.6% +26 pp -€26.22M -25.9% -1,984.9% +23 pp
    €832.48K -€41.11M -4,938.8% -€35.40M -4,252.4%

    Notifications